Erdosteine – A new drug in the treatment of chronic rhinosinusitis

I. Stárek, J. Hoza, P. Schalek, R. Kellnerová (Olomouc, Praha, Brno, Czech Republic)

Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Session: Treatment of asthma, bronchiectasis and cough: inhaler use
Session type: Thematic Poster Session
Number: 2175
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Stárek, J. Hoza, P. Schalek, R. Kellnerová (Olomouc, Praha, Brno, Czech Republic). Erdosteine – A new drug in the treatment of chronic rhinosinusitis. Eur Respir J 2012; 40: Suppl. 56, 2175

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Heliox administration in patients with COPD exacerbation – Technical aspects
Source: Annual Congress 2010 - Mechanical ventilation and weaning
Year: 2010


Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

β2 long-acting and anticholinergic drugs synergistically control TGFβ1-mediated neutrophilic inflammation in COPD: An "in vitro" model
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011


Eosinophilic pneumonia – Our own experience with diagnosis and treatment
Source: Annual Congress 2012 - The good clinical practice: useful case report
Year: 2012


Treatment of sarcoidosis – pentoxifylline
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009

Mechanisms of persistence of Streptococcus pneumoniae following treatment of acute exacerbation of chronic bronchitis
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009


Use of non-steroid antiinflammatory therapy in COPD patients – Clinical effectiveness and influence on the physical tolerance
Source: Annual Congress 2010 - COPD: management
Year: 2010


CPAP therapy withdrawal – A model to evaluate treatments for OSA
Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology
Year: 2011

Complementary and alternative therapy in bronchial asthma – A study from India
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012


Chronic non-asthmatic cough – Are we nearer to define the airway pathology?
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Long term inhalatory therapy in asthma – Achieving control of the disease
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

Clinical analysis of chronic hypersensitivity pneunonitis – Comparison with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010


Mucoactive therapy in COPD
Source: Eur Respir Rev 2009; 19: 134-140
Year: 2010



Intractable breathlessness in COPD – A suitable case for palliation?
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011


Nebulized bimosiamose – anti-inflammatory pan-selectin antagonist for the treatment of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009